MicroPort Medical intends to transfer 12% equity to minimally invasive heart: market value of 218 million yuan

Recently, Wei Chuang Medical announced that on December 3, 2016, the company's wholly-owned subsidiary MicroPort Endovascular CHINA, a wholly-owned subsidiary of MicroPort (Shanghai) Medical Science Investment, a wholly-owned subsidiary of MicroPort Shanghai and the company (collectively referred to as the seller) and MicroPort Medical Technology (Shanghai) (the target company) (hereinafter referred to as Weixin Xinmai) entered into an equity transfer agreement with the relevant investors, pursuant to which the seller agreed to transfer the target company a total of 12% to the relevant investors. The equity, the cost of 218 million yuan, of which, MicroPort Endovascular CHINA holds 84.15% of the shares of MicroPort, and MicroPort (Shanghai) Medical Science Investment holds a 0.85% stake in Microcred.

The announcement shows that on the same day, the Vendor and Wei Chuang Xinxin entered into a capital increase agreement with an independent third party. According to this, Jiu Shen agreed to subscribe for approximately 1.92% of the enlarged share capital of the Target Company at a consideration of RMB 35.55 million. The share capital of the minimally invasive heart will increase from 52.94 million yuan to 53.98 million yuan.

At the same time, the announcement shows that the Equity Transfer Agreement refers to the proposed transfer of 10% equity interest in Microcred Xinmao to the independent third party, and it is recommended to transfer 2% of the equity of Weixin Xinxin to the company's connected person Zhang Jiangke.

MicroPort Medical intends to transfer 12% equity to minimally invasive heart: market value of 218 million yuan

In addition, after independent negotiations with the relevant investors, Shanghai Hongyu, one of the shareholders of Weichuang Xinmai (holding a 15% stake in Microcred), entered into an equity transfer agreement with the investor, agreeing to the long-term , Lianmu and Zhangjiang Science Investment transferred 3%, 1.5% and 0.5% equity of the target company respectively.

MicroPort Medical intends to transfer 12% equity to minimally invasive heart: market value of 218 million yuan

Minimally invasive heart equity structure after the transaction is completed

Laser Distance Meter 40M

40m Laser Distance Meter is a functional and advanced measuring tools, no need climbing up and down, which is the engineers' best friends. No matter you have your own brand or not, JRT can help you to start with laser range finder business. JRT sold more than 1 million OEM laser distance meter modules last year, and we will triple or fifth times of that quantity.
We accept OEM/ODM and customized product.
>1. Logo printed customized: at the back of the instruments etc.
>2. Distance customized: 40m, 60m, 100m, 150m.
>3. Package box customized

Distance Measure Meter,40M Laser Distance Measure,Laser Distance Meter 40M,40M Laser Distance Meter

Chengdu JRT Meter Technology Co., Ltd , https://www.infrareddistancesensor.com